Gene · 406949
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy. | Int J Mol Sci | 2023 | 37686110 | PubTator, text mining | PubMed |
| LncRNA SNHG1: role in tumorigenesis of multiple human cancers. | Cancer Cell Int | 2023 | 37684619 | PubTator, text mining | PubMed |
| Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review. | Cancer Rep (Hoboken) | 2023 | 37675821 | PubTator, text mining | PubMed |
| Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential. | Front Immunol | 2023 | 37675125 | PubTator, text mining | PubMed |
| Molecular immune monitoring in kidney transplant rejection: a state-of-the-art review. | Front Immunol | 2023 | 37675106 | PubTator, text mining | PubMed |
| Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. | World J Gastroenterol | 2023 | 37664153 | PubTator, text mining | PubMed |
| Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37663266 | PubTator, text mining | PubMed |
| Clinically informative microRNAs for SARS-CoV-2 infection. | Epigenomics | 2023 | 37661862 | PubTator, text mining | PubMed |
| Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles. | Front Oncol | 2023 | 37637043 | PubTator, text mining | PubMed |
| Natural Products Treat Colorectal Cancer by Regulating miRNA. | Pharmaceuticals (Basel) | 2023 | 37631037 | PubTator, text mining | PubMed |
| Potential Epigenetic Effects of Human Milk on Infants' Neurodevelopment. | Nutrients | 2023 | 37630804 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Features of Uveal Melanoma-An Overview and Clinical Implications. | Int J Mol Sci | 2023 | 37628989 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Increased Levels of miR-15b-5p and miR-20b-5p in Pancreatic Ductal Adenocarcinoma with Hepatic Metastases. | Genes (Basel) | 2023 | 37628628 | PubTator, text mining | PubMed |
| 3D Culture and Interferon-γ Priming Modulates Characteristics of Mesenchymal Stromal/Stem Cells by Modifying the Expression of Both Intracellular and Exosomal microRNAs. | Biology (Basel) | 2023 | 37626949 | PubTator, text mining | PubMed |
| ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See! | Biomedicines | 2023 | 37626796 | PubTator, text mining | PubMed |
| Somatic mutation effects diffused over microRNA dysregulation. | Bioinformatics | 2023 | 37624931 | PubTator, text mining | PubMed |
| Effects of Controlled Ozone Exposure on Circulating microRNAs and Vascular and Coagulation Biomarkers: A Mediation Analysis. | Noncoding RNA | 2023 | 37624035 | PubTator, text mining | PubMed |
| Crosstalk between Long Non-Coding RNA and Spliceosomal microRNA as a Novel Biomarker for Cancer. | Noncoding RNA | 2023 | 37624034 | PubTator, text mining | PubMed |
| Comprehensive Molecular Evaluation of HNF-1 Alpha, miR-27a, and miR-146 Gene Variants and Their Link with Predisposition and Progression in Type 2 Diabetes Patients. | J Pers Med | 2023 | 37623520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406949/papers?page=12